ARNTL expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 7.463400E-01 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
6.396400E-01 |
Normal-vs-Stage2 |
8.965400E-01 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
8.466200E-01 |
Stage1-vs-Stage2 |
7.930400E-01 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
3.972200E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
7.390600E-01 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
8.185000E-01 |
Normal-vs-AfricanAmerican |
3.265400E-01 |
Normal-vs-Asian |
8.960600E-01 |
Caucasian-vs-AfricanAmerican |
2.085000E-01 |
Caucasian-vs-Asian |
7.290200E-01 |
AfricanAmerican-vs-Asian |
1.249240E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.004000E-01 |
Normal-vs-Female |
6.475200E-01 |
Male-vs-Female |
7.296000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
9.636600E-01 |
Normal-vs-Extreme_Weight |
6.901400E-01 |
Normal-vs-Obese |
8.465200E-01 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
6.950800E-01 |
Normal_Weight-vs-Obese |
8.611000E-01 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
8.370000E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.776000E-01 |
Normal-vs-Age(41-60Yrs) |
5.947600E-01 |
Normal-vs-Age(61-80Yrs) |
8.263400E-01 |
Normal-vs-Age(81-100Yrs) |
2.253600E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.582600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.204000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.067400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.021400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.199400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.472000E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
4.168600E-01 |
Normal-vs-Grade 3 |
4.729600E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
1.899800E-01 |
Grade 2-vs-Grade 4 |
4.168600E-01 |
Grade 3-vs-Grade 4 |
4.729600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
4.521800E-01 |
Normal-vs-N1 |
9.819400E-01 |
N0-vs-N1 |
4.897200E-01 |
|
|